Related Experiment Video
Updated: Aug 9, 2025
Isolation and Functional Analysis of Mitochondria from Cultured Cells and Mouse Tissue
Published on: March 23, 2015
Mitochondrial DNA in cell death and inflammation
Rosalie Heilig1,2, Jordan Lee1,2, Stephen W G Tait1,2
1Cancer Research UK Beatson Institute, Switchback Road, Glasgow G61 1BD, U.K.
Abstract:
Cytosolic DNA is recognized by the innate immune system as a potential threat. During apoptotic cell death, mitochondrial DNA (mtDNA) release activates the DNA sensor cyclic GMP-AMP synthase (cGAS) to promote a pro-inflammatory type I interferon response. Inflammation following mtDNA release during apoptotic cell death can be exploited to engage anti-tumor immunity and represents a potential avenue for cancer therapy. Additionally, various studies have described leakage of mtDNA, independent of cell death, with different underlying cues such as pathogenic infections, changes in mtDNA packaging, mtDNA stress or reduced mitochondrial clearance. The interferon response in these scenarios can be beneficial but also potentially disadvantageous, as suggested by a variety of disease phenotypes. In this review, we discuss mechanisms underlying mtDNA release governed by cell death pathways and summarize release mechanisms independent of cell death. We further highlight the similarities and differences in mtDNA release pathways, outlining gaps in our knowledge and questions for further research. Together, a deeper understanding of how and when mtDNA is released may enable the development of drugs to specifically target or inhibit mtDNA release in different disease settings.
Insights
Mitochondrial DNA (mtDNA) release into the cytosol triggers immune responses. Understanding these release mechanisms, both during cell death and independently, is crucial for developing targeted cancer therapies and managing inflammatory diseases.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Cytosolic DNA, particularly mitochondrial DNA (mtDNA), acts as a danger signal recognized by the innate immune system.
- Release of mtDNA during apoptosis activates cyclic GMP-AMP synthase (cGAS), inducing type I interferon responses, which can be leveraged for anti-tumor immunity.
- mtDNA can also be released independently of cell death due to factors like infection or mitochondrial dysfunction, leading to varied immune outcomes.
Approach:
- This review synthesizes current knowledge on mtDNA release mechanisms.
- It differentiates pathways associated with cell death from those occurring independently.
- The review identifies similarities, differences, and knowledge gaps in mtDNA release processes.
Key Points:
- Apoptotic cell death leads to mtDNA release, activating cGAS and promoting inflammation for potential cancer therapy.
- Non-apoptotic mtDNA leakage, triggered by infections or mitochondrial issues, also elicits immune responses with dual benefits and drawbacks.
- Understanding these diverse mtDNA release pathways is essential for therapeutic development.
Conclusions:
- A comprehensive understanding of mtDNA release mechanisms is vital for developing targeted interventions in various disease contexts.
- Further research into the precise triggers and regulation of mtDNA release can inform novel therapeutic strategies.
- Targeting or inhibiting mtDNA release holds promise for treating inflammatory diseases and enhancing cancer immunotherapy.
Related Concept Videos
01:45Mitochondrial Membranes
01:37Mitochondria
02:59Animal Mitochondrial Genetics
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
01:31The Intrinsic Apoptotic Pathway
01:18Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...